FDA clears Eurand's pancreatic enzyme drug Zenpep - Related Stories - AAP SmartBrief
Links shared publicly online about this topic.
- 1,782total visits
FDA clears Eurand's pancreatic enzyme drug Zenpep - Related Stories - AAP SmartBrief
Eurand in Amsterdam gained FDA approval for its lead product, pancreatic enzyme drug Zenpep, for children age 1 and older as well as adults. The treatment, which is indicated for exocrine pancreatic insufficiency, will be available in four dosages in the U.S. next quarter. <a href='/servlet/aaRedire
View full resource at smartbrief.com
Tags: Pancreatic Disease, Drug, Children's Health, FDA, American Academy of Pediatrics
Most Recently Shared on September 1, 2009 at 3:02 am By:
FDA clears Eurand's pancreatic enzyme drug Zenpep http://sbne.ws/r/2FrT
Advertisement
